Skitii Raises ₹4 Crore at 150% Valuation Increase to Pioneer AI-Powered Emotion-Adaptive Music Therapy for Cancer Care

Mumbai healthtech startup doubles valuation with US angel investor backing; prepares for global regulatory approvals and clinical validation
Mumbai, January 12, 2026 - Mindful Gurukul Private Limited, the DPIIT-recognized healthtech startup behind Skitii, today announced it has raised ₹4 crore in funding from a seasoned US-based angel investor at a 150% increase in valuation. The investment will accelerate clinical trials and regulatory approvals for Skitii's groundbreaking emotion-adaptive music therapy platform-the first system to autonomously generate and adapt therapeutic music in real-time based on cancer patients' emotional and physiological states.
The doubled valuation reflects strong investor confidence in Skitii's innovative technology and its potential to transform non-pharmacological cancer care globally.
Skitii represents a paradigm shift in cancer symptom management. The platform integrates AI-powered emotion recognition with biometric sensors and generative AI to create a closed-loop therapeutic system that continuously adapts music to each patient's changing needs-delivering what no human therapist or pre-recorded intervention could achieve: truly personalized, moment-by-moment care.
"We're seeing exceptional interest from investors who understand the convergence of AI and digital therapeutics," said Dr. Chirag Jain, CEO and Co-founder of Mindful Gurukul. "The 100% valuation increase reflects both the innovation of our technology and the scalability of our approach. We're pioneering a fundamentally new category: an AI system that detects what patients feel, understands their physiological stress through biometric sensors, and generates personalized music therapy that evolves with them in real-time."
The funding will support clinical trials and regulatory submissions for medical device certifications in India (CDSCO), Europe (CE Mark), and the United States (FDA), positioning Skitii as a global leader in AI-driven therapeutic interventions.
"As a doctor with 18 years of clinical experience, I've witnessed how cancer treatment focuses almost exclusively on destroying tumors while largely ignoring the suffering patients endure during the process," added Dr. Jain. "We're building technology that addresses this gap-a living, adaptive intervention that's available 24/7, responding to patients when they need it most. This funding enables us to validate our approach through rigorous clinical trials and bring this innovation to patients globally."
The platform's breakthrough lies in its autonomous operation. Patients simply use their smartphone and biometric sensors-no active engagement required. Skitii's AI continuously monitors emotional states, detects stress patterns, and generates therapeutic music tailored to bring patients toward calm and focus. This represents the first truly scalable, personalized music therapy solution that can reach millions of patients worldwide.
Skitii is pioneering the convergence of frontier technologies-real-time emotion recognition, biometric monitoring, and generative AI music creation-into a single therapeutic platform. The company has filed patents protecting this novel integration and is preparing to partner with hospitals for clinical validation across diverse cancer populations.
The investment from a US-based angel investor at an increased valuation signals growing international interest in India's digital therapeutics sector, particularly in innovative solutions with clear regulatory pathways and strong intellectual property protection.

Media Contact:
Dr. Chirag Jain
CEO & Co-founder
chiragjain@mindfulgurukul.com

417, FLOOR-4,B, CHANDRALOK, MANAV MANDIR ROAD, TEEN BATTI, MALABAR HILL, MUMBAI, Mumbai City, Maharashtra

Mindful Gurukul Private Limited is a Mumbai-based healthcare technology company pioneering emotion-adaptive AI therapeutics for cancer care. Founded by Dr. Chirag Jain (18+ years clinical experience) and Darshana Jain, the DPIIT-recognized startup has developed the world's first platform combining AI-powered emotion detection, biometric sensors, and generative AI to deliver autonomous, personalized music therapy. The company holds patents and is preparing for clinical trials to validate its breakthrough approach to managing cancer treatment symptoms.

This release was published on openPR.